Another study performed on a mouse model of psoriasis showed that systemic blockade of VEGF-A by a monoclonal antibody determined normalization of epidermal proliferation, decreased the size of dermal vessels, and reduced inflammatory cells [61, 66]. This evidence concerns the gene VEGFA and psoriasis.